CRP and diabetes mellitus: In patients with AoAC at baseline, univariate analysis reavealed that diabetes mellitus, previous cardiovascular disease, lipid-lowering therapy, hs-CRP levels, and baseline AoACS were significantly associated with AoAC progression.